• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌钙蛋白 I 与急性冠状动脉综合征左心室射血分数的相关性。

Correlation of Troponin I with Left Ventricular Ejection Fraction in Acute Coronary Syndrome.

机构信息

Mandya Institute of Medical Sciences, Mandya.

出版信息

J Assoc Physicians India. 2022 Apr;70(4):11-12.

PMID:35443386
Abstract

Coronary artery disease is the most common cause of heart disease and the single most important cause of premature death in the world.In 2001,CVD was responsible for 29% of all deaths and 14% of the 1.5 billion lost DALYs.By 2030,when population is expected to reach 8.2 billion,33%of all deaths will be caused by CVD. Over the last decade, cardiovascular disease(CVD) has become the single largest cause of death worldwide. Myocardial necrosis causes release of structural proteins and other intracellular macromolecules into the cardiac interstitium as a consequence of compromise of the integrity of cellular membranes. On the basis of improved sensitivity and superior tissue-specificity compared with the other available biomarkers of necrosis, cardiac troponin is the preferred biomarker for the detection of myocardial injury. Material and Objectives:

  • To determine the correlation between Troponin I with left ventricular ejection fraction in acute coronary syndrome.
Methodology:
  • Source of data: The patients with ACS, who gave written consent for the study, in the IP departments of General Medicine.
  • Study Design: Prospective observational study.
  • Sample size: 75.
Methods of Collection of Data:
  • The present study were conducted on patients diagnosed with ACS. Data regarding patient characteristics including age, sex, gender as well as history of chronic heart disease were collected. Patients evaluated during the hospital stay using daily ECG, troponin I, Ejection fraction of left ventricle measured using echocardiography at the 4th day of admission and catergorised as normal (>50%), mildly reduced(40-50%)and reduced(<40%) EF ced(<40%).
Observation: In this study the mean Troponin I is 8332.47 with a standard deviation of 8371.17. Minimum value is 23 and maximum value is 32000. Maximum Troponin I and Ejection Fraction has been correlated with a Pearson correlation coefficient -0.739,which concludes that Maximum troponin I and EF are highly negatively correlated with a significant p value of <0.001. Conclusion: The present study concludes that serum troponin I level has a strong negative correlation with the left ventricular ejection fraction in patients with acute coronary syndrome and hence can be used to predict the LVEF.

摘要

冠状动脉疾病是心脏病的最常见原因,也是世界上导致过早死亡的单一最重要原因。2001 年,CVD 占所有死亡人数的 29%,占 15 亿人失去 DALYs 的 14%。到 2030 年,预计人口将达到 82 亿时,所有死亡人数的 33%将由 CVD 引起。在过去的十年中,心血管疾病(CVD)已成为全球范围内导致死亡的单一最大原因。心肌坏死导致结构蛋白和其他细胞内大分子因细胞膜完整性受损而释放到心肌间质中。与其他坏死的可用生物标志物相比,心肌肌钙蛋白具有更高的灵敏度和更好的组织特异性,是检测心肌损伤的首选生物标志物。材料和目的:

  • 确定急性冠状动脉综合征中肌钙蛋白 I 与左心室射血分数之间的相关性。
方法:
  • 数据来源:在普通内科 IP 病房中,同意参加研究的急性冠状动脉综合征患者。
  • 研究设计:前瞻性观察性研究。
  • 样本量:75。
数据收集方法:
  • 本研究对象为诊断为 ACS 的患者。收集患者特征的数据,包括年龄、性别、性别以及慢性心脏病史。在住院期间,使用每日心电图、肌钙蛋白 I、第 4 天入院时使用超声心动图测量的左心室射血分数对患者进行评估,并分类为正常(>50%)、轻度降低(40-50%)和降低(<40%)EF ced(<40%)。
观察:在这项研究中,肌钙蛋白 I 的平均值为 8332.47,标准差为 8371.17。最小值为 23,最大值为 32000。最大肌钙蛋白 I 和射血分数与 Pearson 相关系数-0.739 相关,这表明最大肌钙蛋白 I 和 EF 呈高度负相关,具有统计学意义(p 值<0.001)。结论:本研究表明,急性冠状动脉综合征患者血清肌钙蛋白 I 水平与左心室射血分数呈强负相关,因此可用于预测 LVEF。

相似文献

1
Correlation of Troponin I with Left Ventricular Ejection Fraction in Acute Coronary Syndrome.肌钙蛋白 I 与急性冠状动脉综合征左心室射血分数的相关性。
J Assoc Physicians India. 2022 Apr;70(4):11-12.

引用本文的文献

1
Cardiac damage after polytrauma: the role of systematic transthoracic echocardiography - a pilot study.多发伤后的心脏损伤:经胸超声心动图系统检查的作用——一项试点研究
World J Emerg Surg. 2025 Mar 11;20(1):21. doi: 10.1186/s13017-025-00596-5.